PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.87%
Revenue growth above 1.5x 3088.T's 2.99%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
12.17%
Gross profit growth above 1.5x 3088.T's 1.93%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
54.90%
EBIT growth above 1.5x 3088.T's 15.31%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
49.18%
Operating income growth above 1.5x 3088.T's 1.99%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
14.74%
Net income growth comparable to 3088.T's 16.11%. Walter Schloss might see both following similar market or cost trajectories.
14.74%
EPS growth similar to 3088.T's 16.18%. Walter Schloss would assume both have parallel share structures and profit trends.
14.74%
Similar diluted EPS growth to 3088.T's 16.14%. Walter Schloss might see standard sector or cyclical influences on both firms.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
149.77%
10Y revenue/share CAGR 1.25-1.5x 3088.T's 132.49%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
59.05%
5Y revenue/share CAGR at 75-90% of 3088.T's 78.17%. Bill Ackman would encourage strategies to match competitor’s pace.
38.14%
3Y revenue/share CAGR under 50% of 3088.T's 89.02%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
199.81%
Below 50% of 3088.T's 636.37%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
61.16%
5Y net income/share CAGR at 75-90% of 3088.T's 79.15%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
30.34%
Below 50% of 3088.T's 123.86%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
318.66%
10Y equity/share CAGR 1.25-1.5x 3088.T's 249.83%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
81.97%
5Y equity/share CAGR at 50-75% of 3088.T's 144.33%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
35.33%
Below 50% of 3088.T's 112.06%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.30%
Our AR growth while 3088.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
0.78%
Inventory shrinking or stable vs. 3088.T's 3.44%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
1.69%
Positive asset growth while 3088.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.49%
BV/share growth above 1.5x 3088.T's 0.55%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-21.26%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
5.14%
We expand SG&A while 3088.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.